Inhibrx Biosciences Inc (NQ: INBX )
14.30
+1.31
(+10.08%)
Streaming Delayed Price
Updated: 11:25 AM EDT, Aug 23, 2024
Add to My Watchlist
All News about Inhibrx Biosciences Inc
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://cdn.benzinga.com/files/images/story/2024/06/05/Health-care-cost-illustration.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://mms.businesswire.com/media/20240509121527/en/1919461/22/Latest_KSF_M%26A.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/04/26/inbx.png?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2020/07/biopharma-1600.jpg)
![](https://talkmarkets.com/images/logos/talkmarkets.png)
![](https://mms.businesswire.com/media/20240210646444/en/1919461/22/Latest_KSF_M%26A.jpg)
![](https://www.investors.com/wp-content/uploads/2017/03/stock-pharmaceutical-1-adobe.jpg)
![](https://mms.businesswire.com/media/20240123115886/en/1567526/5/Firm_Logo-with_Investor_Law_Firm.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/10/04/aapharma_1.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/Sanofi_0.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/Sanofi.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/08/31/domo_-_logo_0.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/08/29/nio_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/08/29/pdd_holdings_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU33.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/11/16/inbx_logo_light__da7d3fdfba4ae30a576a3b75fa28b934.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/13/image17.jpg?width=1200&height=800&fit=crop)
![](https://schaeffers-cdn.s3.amazonaws.com/images/default-source/schaeffers-cdn-images/2022/october/mmc/midday-market-stats-october-052022.png?sfvrsn=e28dad06_2)
![](https://cdn.benzinga.com/files/images/story/2022/11/18/image30.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/04/image38.jpeg?width=1200&height=800&fit=crop)
R&D Efforts to Improve Optimal Treatments for Advanced Pancreatic Ductal Adenocarcinoma (PDAC) Progressing
October 05, 2022
Topics
Death
Exposures
Death
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_18416.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/04/image12.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/04/image23.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/04/image39.jpeg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.